CTRI/2013/12/004220已完成未知
A single blind randomized, single centre,prospective, three treatment, placebo controlled, clinical study to evaluate the safety and efficacy of EPA in adult human male and female subjects with abdominal obesity.
Parry Neutraceuticals0 个研究点目标入组 18 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Adult male and female subjects between 18 and 50 yrs (both years inclusive)
- •Willingness to provide written informed consent to participate in the study
- •Understanding the nature and purpose of the study and willing to comply with study procedures
- •Abdominal girth of more than or equal to 102 cm
- •Serum triglycerides equal to or greater than 150 mg/dL and HDL cholesterol Less than 40 mg/dL
- •Negative for HIV 1 & 2, Hepatitis B & C
排除标准
- •Subjects not capable of understanding the informed consent
- •Subjects who are on lipid lowering treatment including Statins, fibrates, etc or who are in need of lipid lowering treatment.
- •Subjects with significant hyperglycemia and / or systemic hypertension with related complications including, renal, hepatic, retinal, cardiac, cerebral disorders.
- •Obesity because of identified etiologies such as Cushingâ??s syndrome, hypothyroidism, etc.
- •On a treatment regimen that includes metformin or glitazones
研究者
相似试验
已完成
4 期
A Post Marketing study of Homeopathic medication Gastroplex® Syrup in Indian Patients with stomach discomfort.CTRI/2023/01/049226Powell Laboratories (P) Limited60
进行中（未招募）
不适用
A single center, randomized, partially blind, placebocontrolled, crossover, single oral dose study to assess theeffect of concomitant antacid (calcium carbonate) on thepharmacokinetics and pharmacodynamics of SMC021 (0.8mg salmon calcitonin/200 mg 5-CNAC) in healthypostmenopausal womeOsteoporosis, osteoarthritisMedDRA version: 8.1Level: LLTClassification code 10031282Term: OsteoporosisEUCTR2006-004177-95-DKovartis Pharma Services AG38
进行中（未招募）
不适用
A single-centre randomised, partially blind, single dose, crossover pilot study investigating the use of stopwatches to assess the onset of action of soothing and cooling of Gaviscon Peppermint Liquid, Double Action Gaviscon Liquid, Gaviscon Advance Liquid and a control in subjects with heartburn following a refluxogenic meal.Symptoms of heartburnEUCTR2007-005821-31-GBReckitt Benckiser Healthcare UK) Limited
进行中（未招募）
不适用
A single-centre randomised, partially blind, single dose, crossover study investigating the onset of action of soothing and cooling after taking Gaviscon Peppermint liquid, Double Action Gaviscon liquid, Gaviscon Instants Oral Powder, compared to a control in subjects with heartburn following a refluxogenic meal, using the 2-stopwatch technique - Gaviscon Soothing and CoolingSymptoms of heartburnEUCTR2008-006413-25-GBReckitt Benckiser Healthcare (UK) Limited
已完成
2 期
Clinical study of Four Hair Oils in Hair loss in femalesCTRI/2018/05/013899Emami Ltd200